MedTrace Logo

Parathyroid Allotransplant for Treatment of Hypoparathyroidism

NCT06961071 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2026-02-27

No results posted yet for this study

Summary

This study is being done to see if transplanting parathyroid tissue into the forearm will help hypo-parathyroid patients achieve parathyroid hormone (PTH) levels that would help normalize their serum calcium and phosphorus levels. The parathyroid tissue used in this study will come from cadaveric tissues that were donated at the time of the death of the donor(s).

Conditions

  • Hypoparathyroidism
  • Hypoparathyroidism Postprocedural
  • Hypoparathyroidism Post-surgical

Interventions

BIOLOGICAL

Parathyroid Allotransplant

Parathyroid Allotransplant

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Peter Stock

    lead OTHER

Principal Investigators

  • Peter Stock, MD, PhD · University of California, San Francisco

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2028-01-15
Completion
2028-01-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06961071 on ClinicalTrials.gov